Abstract:Background: Dysregulated splicing events are a common phenomenon in cancer with the Serine-arginine-rich splicing factor (SRSF) family emerging as pivotal regulators of gene expression, exerting influence over constitutive and alternative splicing processes. Although aberrations in a few SRSF family members have been implicated in various cancers, the comprehensive roles of other family constituents remain underexplored. Methods: This study delves into the expression profile of the entire SRSF family (SRSF1-SRSF12) in 23 cancerous cell lines originating from diverse tissues using quantitative Real-Time PCR. Further, the transcript levels of the SRSF family were examined in oral cancer patient samples stratified into Pre-cancer (n = 15), Early cancer (n = 11), Late cancer (n = 14), and adjacent non-tumor tissues (n = 26) as controls. The results were corroborated by a parallel investigation utilizing the transcriptomics data of oral squamous cell carcinoma (OSCC) patients (n = 319) and controls (n = 35) available in The Cancer Genome Atlas (TCGA) database. Results: Our investigation reveals a notable upregulation in the expression levels of key splicing factors, namely SRSF3, SRSF9, and SRSF10 in all oral cancer cell lines (SCC-4, UM-SCC-84, CAL33, SAS-H1). Conversely, no significant associations between SRSF family members and other cancer cell lines were discerned. Further, the expression profile of the SRSF family in oral cancer patient samples revealed significant upregulation of SRSF1, SRSF3, SRSF7, SRSF9, SRSF10, and SRSF11 in patients with late-stage oral cancer compared to controls. Transcriptomics data from TCGA database demonstrated remarkable upregulation of SRSF1, SRSF4, SRSF9, SRSF10, and SRSF11 in OSCC patients. Conclusion: Collectively our results underscore the critical involvement of SRSF family members in the context of oral cancer, highlighting their potential as key players in the altered splicing dynamics associated with cancer progression.

SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma.

Expression of SRSF3 is Correlated with Carcinogenesis and Progression of Oral Squamous Cell Carcinoma

Oncogenic SRSF3 in Health and Diseases.

SRSF6-regulated Alternative Splicing That Promotes Tumour Progression Offers a Therapy Target for Colorectal Cancer

HnRNP L is important for the expression of oncogene SRSF3 and oncogenic potential of oral squamous cell carcinoma cells

High Expression of SRSF10 Promotes Colorectal Cancer Progression by Aberrant Alternative Splicing of RFC5

SRSF3 Functions As an Oncogene in Colorectal Cancer by Regulating the Expression of ArhGAP30

Biological Function and Molecular Mechanism of SRSF3 in Cancer and Beyond (Review)

A Genome Landscape of SRSF3-regulated Splicing Events and Gene Expression in Human Osteosarcoma U2OS Cells.

SRp20 is a Proto-Oncogene Critical for Cell Proliferation and Tumor Induction and Maintenance.

Oncogenic Splicing Factor SRSF3 Regulates ILF3 Alternative Splicing to Promote Cancer Cell Proliferation and Transformation

SRSF3 Suppresses RCC Tumorigenesis and Progression Via Regulating SP4 Alternative Splicing

Emerging Roles of SRSF3 As a Therapeutic Target for Cancer

Targeting Splicing Factor SRSF6 for Cancer Therapy

Serum Response Factor-Regulated IDO1/Kyn-Ahr Pathway Promotes Tumorigenesis of Oral Squamous Cell Carcinoma

SRSF3 Promotes Angiogenesis in Colorectal Cancer by Splicing SRF

Exploring serine-arginine rich splicing factors: potential predictive markers for dysregulation in oral cancer

The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers

Splicing Factor ESRP1 Derived Circ_0068162 Promotes the Progression of Oral Squamous Cell Carcinoma Via the Mir-186/Jag Axis.

SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes

High expression of SRSF1 facilitates osteosarcoma progression and unveils its potential mechanisms